Maitalon

Drospirenone, the active ingredient in Maitalon, is a combined oral contraceptive presented as a tablet for oral use. Together with ethinylestradiol, it works to prevent unintended pregnancy and to provide cycle regulation for women of reproductive age, offering both contraceptive efficacy and menstrual cycle control. The formulation is approved in the European Union and is prescribed by healthcare professionals as part of a comprehensive family planning strategy.

GNH USA supplies Maitalon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance for global distribution.

Maitalon, a combined oral contraceptive, is used to manage reproductive health by influencing hormonal regulation. - Contraception: provides reliable prevention of unintended pregnancy in women of childbearing potential. - Regulation of menstrual cycles: helps establish predictable menstrual bleeding patterns. - Treatment of dysmenorrhea: reduces menstrual pain and associated symptoms.

Maitalon may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: occasional stomach upset, especially when treatment is initiated. - Headache: mild to moderate tension‑type headaches. - Breast tenderness: temporary swelling or discomfort of the breasts. - Spotting between periods: irregular light bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins, potentially life‑threatening. - Stroke: rare cerebrovascular event, more likely in high‑risk individuals. - Severe hypertension: significant rise in blood pressure requiring medical attention.

Before prescribing Maitalon, clinicians should consider several safety factors. - Assess cardiovascular risk: evaluate history of thrombosis, smoking, hypertension, or obesity. - Contraindicated in pregnancy: avoid use because of teratogenic risk (Category X). - Monitor blood pressure: oral contraceptives may increase systolic and diastolic values. - Review concomitant medications: enzyme‑inducing drugs can reduce effectiveness. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Maitalon can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may markedly reduce contraceptive effect. - Antifungal azoles (e.g., ketoconazole, itraconazole): can increase hormone levels, raising risk of side effects. - Rifampin and other strong inducers: may significantly decrease effectiveness.

Moderate Interactions (Monitor Closely): - Broad‑spectrum antibiotics (e.g., tetracycline, metronidazole): possible modest reduction in absorption. - St. John’s wort: may lower plasma hormone concentrations. - Diuretics: can affect fluid balance and blood pressure, requiring observation.